News & Updates

A modified dual therapy as first-line treatment for H. pylori infection demonstrates equal efficacy and compliance relative to recommended regimens, reveals a study. Moreover, a generally modified dual therapy has fewer side effects.

Though promising, coronavirus disease 2019 (COVID-19) symptom checkers—online, patient-led triage systems—are unable to reliably distinguish mild from severe COVID-19 and may instead put the public and healthcare workers at greater risk of infection, according to a recent study.

Administrating continuous positive airway pressure (CPAP) through a helmet (h-CPAP) device safely improves oxygenation in women with moderate-to-severe acute respiratory failure (ARF) due to the coronavirus disease 2019 (COVID-19), a recent study has found.

In immunocompetent patients admitted at a community hospital, comorbidities such as advanced gastric cancer and atrophic gastritis (AG), as well as treatment with proton pump inhibitors (PPI), seem to aggravate the risk of developing oesophageal candidiasis (EC), a recent study has found.

Use of therapeutic heparin does not appear to significantly reduce the death, mechanical ventilation, or intensive care unit (ICU) admission in hospitalized patients with moderate COVID-19 and increased D-dimer levels, reveals a study. However, it is associated with a significantly lower chances of all-cause death and reduced risk of major bleeding.

In a systematic review and meta-analysis, glycaemic parameters in patients with type 1 diabetes (T1D) improved during the COVID-19 lockdown periods. Conversely, patients with type 2 diabetes (T2D) had short-term worsening of glycaemic values.

Reopening workplaces and establishments after the lifting of coronavirus disease 2019 (COVID-19) lockdowns leads to an increase in physical activity as well as notable shifts in sleep patterns and mental wellbeing, according to a recent Singapore study.